Form 8-K - Current report:
SEC Accession No. 0001213900-25-061778
Filing Date
2025-07-07
Accepted
2025-07-07 16:13:49
Documents
14
Period of Report
2025-06-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0248265-8k_bespoke.htm   iXBRL 8-K 22449
2 PRESS RELEASE DATED JUNE 30, 2025 ea024826501ex99-1_bespoke.htm EX-99.1 60321
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6383
  Complete submission text file 0001213900-25-061778.txt   260464

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20250630.xsd EX-101.SCH 3035
5 XBRL LABEL FILE bspk-20250630_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE bspk-20250630_pre.xml EX-101.PRE 22372
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0248265-8k_bespoke_htm.xml XML 3345
Mailing Address 12001 E. 33RD ST- UNIT O AURORA CO 80010
Business Address 12001 E. 33RD ST- UNIT O AURORA CO 80010 720-949-1143
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

EIN.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 251108178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)